Miriam Kull
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- RNA Research and Splicing
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 12
- Acute Myeloid Leukemia Research 2
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Hesham EldalyCornelius F. WallerUwe M. MartensStefan ZimmermannMilena PantićChristian LangerStefan KnopHermann Einsele
- Journals
- Blood (3 papers)Annals of Hematology (1 paper)Antibiotics (1 paper)Cytometry Part A (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Miriam Kull
14 papers receiving 332 citations
Peers
Comparison fields: 5 of 43
- Hematology 130
- Molecular Biology 279
- Physiology 86
- Oncology 61
- Biotechnology 19
Countries citing papers authored by Miriam Kull
This map shows the geographic impact of Miriam Kull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Kull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Kull more than expected).
Fields of papers citing papers by Miriam Kull
This network shows the impact of papers produced by Miriam Kull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Kull. The network helps show where Miriam Kull may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miriam Kull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 42 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 16 | |
| 9 | 2018 | 10 | |
| 10 | 2018 | 0 | |
| 11 | 2017 | 1 | |
| 12 | 2016 | 36 | |
| 13 | 2016 | 3 | |
| 14 | 2015 | 36 | |
| 15 | 2014 | 51 | |
| 16 | 2004 | 120 |
About Miriam Kull
Miriam Kull is a scholar working on Hematology, Genetics, Molecular Biology, Orthopedics and Sports Medicine and Emergency Medicine, having authored 16 papers that have together received 335 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (6 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer therapeutics and mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Salmonella and Campylobacter epidemiology (1 paper). The work is most often cited by research in Hematology (130 citations), Molecular Biology (279 citations), Physiology (86 citations), Oncology (61 citations) and Biotechnology (19 citations). Miriam Kull has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hesham Eldaly, Cornelius F. Waller, Uwe M. Martens, Stefan Zimmermann, Milena Pantić, Christian Langer, Stefan Knop, Hermann Einsele, Ralf C. Bargou and Lars Bullinger. Their work appears in journals such as Blood, Annals of Hematology, Antibiotics, Cytometry Part A and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.